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Abstract: We describe three eyes of two cases of severe degeneration of the macula following vitrectomy with indo-
cyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. We need to remember the possibil-
ity of these complications and have to select the procedures that are safest to use for macular hole surgery. 
INTRODUCTION 
  Staining the internal limiting membrane (ILM) with in-
docyanine green (ICG) and peeling it during vitrectomy has 
greatly improved the rate of macular hole closure [1-3]. This 
ICG-assisted ILM peeling has become a very common pro-
cedure to treat macular holes, although various complica-
tions have been reported including visual field defects, reti-
nal tears and detachments, and other alterations of the poste-
rior segment [4-12]. These complications are not always 
attributable to the ILM peeling or use of ICG, and chori-
oretinal injuries can be caused by light damage during the 
surgery and the contact of the retina with the gas used to 
tamponade the retina [6]. 
  We report two cases of idiopathic macular holes which 
developed extensive macular degeneration with hyperplasia 
of the retinal pigment epithelium in the ILM peeled area, 
although the macular holes were successfully closed. 
CASE REPORT 
Case 1 
  A 63-year-old woman had a stage III macular hole in the 
right eye and a stage IV in the left eye (Fig. 1). She had 6 
months history of decreased vision in her right eye and 2 
months in her left eye. Her corrected visual acuity was 20/50 
OD and 20/30 OS. Phacoemulsification and aspiration,   
 
 
*Address correspondence to this author at the Department of Ophthalmol-
ogy, Juntendo University Urayasu Hospital, Japan;  
E-mail: mizota@juntendo-urayasu.jp 
intraocular lens implantation, and vitrectomy were per-
formed on the right eye followed by the left eye. The ILM 
was stained with 0.5% ICG, and a three to four disc diameter 
area of ILM was peeled and removed. The initial flap for 
peeling the ILM was created on the temporal side in each 
eye. Then 1.0 ml of pure SF6 gas was injected to tamponade 
the retina. The patient maintained a prone position for 24 
hours on the first postoperative day and only during the day 
on the following 7 days. 
  One week after the surgery, the macular holes were con-
firmed to be closed (Fig. 2). However, degenerative changes 
developed in the macula about 2 weeks after the surgery, 
especially on the temporal side of the fovea in both eyes. A 
yellow, round degenerative lesion was noted in the fovea, 
and irregular degenerative foci associated with pigment de-
posits were found just temporal to the lesion. The changes 
were more marked in the right eye (Fig. 3a,b). The surgical 
procedures and clinical course of left eye was similar to the 
right eye. 
  Although retinal vessels appeared ophthalmoscopically 
normal, fluorescein angiography (FA) revealed areas of hy-
pofluorescein and blockage of the fluorescein in the area of 
the pigment epithelial cell proliferation. The area surround-
ing the pigment cell proliferation was hyperfluorescein, but 
tiny hypofluorescein spots were detected within the hyper-
fluorescein area (Fig. 4a,b). 
  These pathological changes did not progress, but the vis-
ual acuity decreased to 20/60 in the right eye and 20/40 in 
the left eye at 6 months after surgery. 
 
 
Fig. (1). Preoperative optical coherence tomography of both eyes in case 1. Left figure shows right eye (stage III) and right figure is left eye 
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Case 2 
  A 55 year-old woman had a stage IV macular hole in her 
left eye (Fig. 5a). She had 2 months history of decreased 
vision in her left eye. Her corrected visual acuity was 20/20 
OD and 20/60 OS. Phacoemulsification and aspiration, in-
traocular lens implantation, and vitrectomy were performed. 
After injecting 0.5% ICG to stain the ILM, a 3 disc diameter 
area of the ILM was peeled and 0.1 ml of pure SF6 gas was 
injected. The initial flap of ILM was created from the tempo-
 
Fig. (5). Optical coherence tomograms of left eye of Case 2. a: Preoperative optical coherence tomogram showing stage IV macular hole.  
b: Postoperative optical coherence tomogram showing that the macular hole is closed. 
 
Fig. (2). Postoperative optical coherence tomography in case 1. Left figure is the right eye and the right figure is the left eye. Both holes are 
closed. 
 
Fig. (3). Postoperative fundus photograph of case 1. A yellow round degenerative lesion is seen in the fovea. Irregular degeneration foci 
associated with pigment deposition can be seen just temporal to the lesion. (a, right eye; b, left eye). 
 
Fig. (4). Fluorescein angiogram taken after vitrectomy shows hypofluorescence or blockage of dye in the area with pigment epithelial prolif-
eration in case 1. Hyperfluorescence is noted in the area surrounding the pigment cell proliferation. Many tiny hypofluorescent spots are seen 
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ral side of the fovea, and it took about one minute to peel the 
ILM. The patient maintained a prone position on the same 
schedule as Case 1. The macular hole was closed 1 week 
after the surgery (Fig. 5b), however hyperpigmentation de-
veloped around macular hole and round degenerative 
changes were noted within the area of the peeled ILM about 
2 weeks after the surgery (Fig. 6). FA revealed areas of hy-
pofluorescein or a blockage of the fluorescein as seen in 
Case 1. (Fig. 7a) Indocyanine green angiography (ICGA) 
showed hypofluorescein in the area where the ILM was 
peeled (Fig. 7b). His visual acuity was 20/40 in the left eye 6 
months after the surgery. 
 
Fig. (6). Postoperative fundus photograph showing hyperpigmenta-
tion around the macular hole and degeneration of pigment the epi-
thelium within the peeled area of internal limiting membrane in 
case 2. 
  Written informed consent was obtained to use ICG dur-
ing surgery from both cases. 
DISCUSSION 
  Pigment epithelial cell degeneration in the macula is a 
relatively rare complication of macular hole surgery with a 
frequency of 2% to 75% [5-7]. It is generally believed that 
retinal pigment epithelium damage is caused by surgical 
trauma during the creation of the initial flap in the ILM and 
from the abrasive suctioning on the floor of macular hole. 
Sivalingam et al. [13] reported that the visual prognosis was 
poorer and the recurrence of an epimacular membrane was 
higher in eyes where ILM components were found in the 
epimacular membrane removed during vitreous surgery than 
in eyes where ILM components were not found. It was also 
reported that postoperative cellular proliferation occurred 
around the edges of the peeled ILM [14]. Tognetto et al. [3] 
reported that better visual improvement was obtained when 
the macular hole was closed without ILM peeling. Taken 
together, these findings suggest that ILM peeling may have 
some adverse effects on the retina. 
  ICG has been shown to be toxic to human retinal pigment 
epithelial cells in vitro [15, 16] and in animal experiments 
[17]. In clinical cases, retinal pigment epithelium atrophy,   
 
 
Fig. (7). Fluoresceint angiogram and indocyanine green angiogram 
of the left eye of Case 2. a: Postoperative fluorescein angiogram 
showing hypofluorescence and hyperfluorescence areas. b: Postop-
erative indocyanine green angiogram showing hypofluorescence in 
the area where ILM was peeled. 
potentiation of phototxicity, visual field defects, alteration of 
ILM-retinal cleavage plane by allowing more inner retinal 
element adherence to the removed ILM, and optic atrophy 
have been reported after the use of ICG during vitreous sur-
gery [8-12]. Complications in the posterior segment have 
also been reported after maintaining the prone positioning 
for a long duration with an expansive gas tamponade [6, 7]. 
  We peeled the ILM, used relatively high concentration of 
ICG, and used SF6. These 3 factors, individually or in com-
bination, might have caused the macular degeneration in our 
cases. But the contact of the SF6 with the macula was for 
only a relatively short time compared with reported cases in 
the literature [6, 7] and other cases in our institution. There-
fore, the SF6 tamponade was most likely not the cause of the 
macular degeneration in our cases. 
  ICG staining makes the ILM more visible, and ICG-
assisted ILM peeling was performed after creating a poste-
rior vitreous detachment during the macular hole surgery.   
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The ILM was removed easily within one minute because of 
its visibility. To reduce potential light toxicity, the intraocu-
lar fiber optic observation light was directed as far away as 
possible from the macular hole. 
  The pattern of macular degeneration in these two cases 
differed from each other. In Case 1, the pigment proliferation 
and epithelial cell atrophy developed on the temporal side of 
the fovea in both eyes. In Case 2, the area of degeneration 
almost coincided with the ILM peeled area. In Case 1, light 
damage was considered to be the cause of macular degenera-
tion because degeneration occurred at the site of the initial 
flap of the ILM was created during surgery. However, illu-
mination on the retina was not excessive in our cases, and 
the duration of the surgery was similar to other cases without 
macular degeneration. In Case 2, the area of degeneration 
roughly coincided with the area of ILM peeling. At the time 
of ILM peeling, the concentration of ICG in the vitreous 
must have been very low, but the ICG was in direct contact 
with the retina without the ILM. In this case, the correspon-
dence of the area of retinal pigment epithelium degeneration 
and the area of ILM peeled strongly suggest that the degen-
eration was due to ICG toxicity. 
  In conclusion, our two cases demonstrated that a degen-
eration of the retina can occur after ICG-assisted ILM peel-
ing during vitrectomy for a macular hole. The complications 
are relatively rare but we need to remember the possibility, 
demonstrated that a degeneration of the retina can occur after 
ICGassisted ILM peeling during vitrectomy for a macular 
hole and have to select the procedures that are safest to use 
for macular hole surgery in each case [2, 18, 19]. 
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